Andrew D Simmons

Andrew D Simmons

UNVERIFIED PROFILE

Are you Andrew D Simmons?   Register this Author

Register author
Andrew D Simmons

Andrew D Simmons

Publications by authors named "Andrew D Simmons"

Are you Andrew D Simmons?   Register this Author

14Publications

801Reads

28Profile Views

Discovery of a mutant-selective covalent inhibitor of EGFR that overcomes T790M-mediated resistance in NSCLC.

Cancer Discov 2013 Dec 24;3(12):1404-15. Epub 2013 Sep 24.

1Clovis Oncology Inc., San Francisco, California; 2Celgene Avilomics Research, Bedford, Massachusetts; 3Division of Hematology-Oncology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee; 4Mouse Cancer Genetics Program; and 5Center for Advanced Preclinical Research, Science Applications International Corporation-Frederick, Inc., National Cancer Institute, Frederick, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-13-0314DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4048995PMC
December 2013

Local secretion of anti-CTLA-4 enhances the therapeutic efficacy of a cancer immunotherapy with reduced evidence of systemic autoimmunity.

Cancer Immunol Immunother 2008 Aug 31;57(8):1263-70. Epub 2008 Jan 31.

Cell Genesys, Inc., 500 Forbes Blvd, South San Francisco, CA 94080, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-008-0451-3DOI Listing
August 2008

Efficient Tet-dependent expression of human factor IX in vivo by a new self-regulating lentiviral vector.

Mol Ther 2005 May;11(5):763-75

Institute for Cancer Research and Treatment, University of Torino Medical School, Strada Provinciale 142, 10060 Candiolo, Turin, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ymthe.2004.11.017DOI Listing
May 2005